Novalis Lifesciences Investments Ii, L.p. - Net Worth and Insider Trading

Novalis Lifesciences Investments Ii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Novalis Lifesciences Investments Ii, L.p. owns 1 companies in total, including Telesis Bio Inc (TBIO) .

Click here to see the complete history of Novalis Lifesciences Investments Ii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Novalis Lifesciences Investments Ii, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
TBIO	Telesis Bio Inc	2023-06-05	10 percent owner

Novalis Lifesciences Investments Ii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Novalis Lifesciences Investments Ii, L.p. Ownership Network

Ownership Network List of Novalis Lifesciences Investments Ii, L.p.

No Data

Ownership Network Relation of Novalis Lifesciences Investments Ii, L.p.

Novalis Lifesciences Investments Ii, L.p. Owned Company Details

What does Telesis Bio Inc do?

Who are the key executives at Telesis Bio Inc?

Novalis Lifesciences Investments Ii, L.p. is the 10 percent owner of Telesis Bio Inc. Other key executives at Telesis Bio Inc include 10 percent owner Marijn E Dekkers , 10 percent owner Novalis Lifesciences Investments Ii Gp, Llc , and 10 percent owner Broadoak Fund Iv, Llc .

Telesis Bio Inc (TBIO) Insider Trades Summary

Over the past 18 months, Novalis Lifesciences Investments Ii, L.p. made no insider transaction in Telesis Bio Inc (TBIO). Other recent insider transactions involving Telesis Bio Inc (TBIO) include a net purchase of 119,941 shares made by Todd Robert Nelson , a net sale of 1,190 shares made by Daniel Glenn Gibson , and a net sale of 1,174 shares made by Rob Cutler .

In summary, during the past 3 months, insiders sold 0 shares of Telesis Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,939 shares of Telesis Bio Inc (TBIO) were sold and 122,516 shares were bought by its insiders, resulting in a net purchase of 117,577 shares.

Telesis Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Telesis Bio Inc Insider Transactions

No Available Data

Novalis Lifesciences Investments Ii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Novalis Lifesciences Investments Ii, L.p.. You might contact Novalis Lifesciences Investments Ii, L.p. via mailing address: 1 Liberty Lane E, Suite 112, Hampton Nh 03842.

Discussions on Novalis Lifesciences Investments Ii, L.p.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.